Industry

In a new report, the United Nations Special Rapporteur on the right to health, Dr. Dainius Pūras, calls for a move away from the biomedical model and “excessive use of psychotropic medicines.”

A new article explains common misconceptions about ADHD that are held by teachers and mental health professionals and may lead to overdiagnosis and overmedication in schools.

A review of academic textbooks finds that they often leave out effect sizes and molecular genetics findings, both of which suggest minimal impact of genetics on ADHD. Instead, textbooks focus on overblown conclusions from behavioral studies.

Implementing policies that regulate pharmaceutical sales representatives’ interaction with physicians may reduce prescription of promoted drugs.

Amid calls for a retraction, Lancet Psychiatry publishes articles criticizing the original finding and a response from the authors.

Previously taking antidepressants could make individuals less likely to respond to treatment for bipolar II depression.

Study finds that 74% of patients with a psychotic disorder off antipsychotics at end of 10 years are in remission.

Study finds more patients are visiting physicians who have ties to industry than previously thought.

“This research points to the inadequacy of asking the simple question: ‘Do antidepressants work?’ Instead, the value or otherwise of antidepressants needs to be understood in the context of the diversity of experience and the particular meaning they hold in people’s lives.”

The American Psychological Association (APA) recently published a study finding that patients assigned to drug-only treatments were more likely to refuse treatment, and more likely to drop out before treatment completion, than patients assigned to psychotherapy only.

Behind the U.S. task force recommendation to screen all children and adults for depression.

Three phase III clinical trials assessing the efficacy of Lundbeck’s investigational drug idalopirdine for Alzheimer’s disease have failed

Despite little evidence for benefit, and substantial risk of harm, antipsychotics are commonly prescribed to children diagnosed with ADHD

Sir Robin Murray, a professor at the Institute of Psychiatry, Psychology, and Neuroscience in London, states that he ignored social factors that contribute to ‘schizophrenia’ for too long. He also reports that he neglected the negative effects antipsychotic medication has on the brain.

New research investigates the financial conflicts of interest (FCOI) of patient advocacy organizations (PAOs) in the United States.

A new study analyzing over 21,000 participants found that differences in activation of brain regions in different psychological “disorders” may have been overestimated, and confirms that there is still no brain scan capable of diagnosing a mental health concern.

BPS releases report encouraging behavioral interventions for people with dementia, rather than antipsychotics

Researchers recommend that healthcare professionals be vigilant regarding the signs of respiratory failure among patients with COPD who are receiving antipsychotics, especially during the initial treatment phase.

New research suggests that treatable metabolic abnormalities underlie some treatment-resistant cases of depression—and treating the metabolic condition has the possibility of dramatically reducing depressive symptoms

The researchers conclude that industry funding appears to bias studies towards pharmacotherapy over psychotherapy for the treatment of depression.

The researchers find that the drug effects for reducing psychosis are small and that treatment failure and severe side effects are common.

Researchers find no benefits for testosterone as a treatment for improving mood, psychological well-being, and cognitive function.

Researchers discuss the preliminary results of clinical trial data sharing efforts by pharmaceutical companies and other groups.

The Nordic Cochrane Center conducted a systematic review of existing research trials on antidepressants and found that the drugs doubled the risk of feelings...